Growth Metrics

Innoviva (INVA) Operating Expenses (2016 - 2025)

Innoviva (INVA) has disclosed Operating Expenses for 16 consecutive years, with $107.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses rose 13.66% year-over-year to $107.2 million, compared with a TTM value of $173.5 million through Dec 2025, up 9.18%, and an annual FY2025 reading of $143.9 million, up 11.27% over the prior year.
  • Operating Expenses was $107.2 million for Q3 2025 at Innoviva, up from $34.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $107.2 million in Q3 2025 and bottomed at -$219.2 million in Q3 2022.
  • Average Operating Expenses over 5 years is $16.3 million, with a median of $34.3 million recorded in 2024.
  • The sharpest move saw Operating Expenses plummeted 2553.12% in 2021, then skyrocketed 1956.38% in 2022.
  • Year by year, Operating Expenses stood at -$104.6 million in 2021, then crashed by 109.53% to -$219.2 million in 2022, then surged by 91.47% to -$18.7 million in 2023, then skyrocketed by 604.75% to $94.4 million in 2024, then rose by 13.66% to $107.2 million in 2025.
  • Business Quant data shows Operating Expenses for INVA at $107.2 million in Q3 2025, $34.4 million in Q2 2025, and $31.9 million in Q1 2025.